Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 Mar 31;105(2):348–349. doi: 10.1016/j.jhin.2020.03.025

Inactivation of coronaviruses by heat

G Kampf a,, A Voss b, S Scheithauer c
PMCID: PMC7271332  PMID: 32243951

Sir

The global spread of COVID-19 has resulted in a huge demand for personal protective equipment including face masks [1]. Even some hospitals face a substantial shortage of suitable face masks (e.g. FFP masks or N95 masks) resulting in an evaluation of various procedures to reprocess them for a limited re-use. Although they are classified as single use products the question was raised if a thermal disinfection may be effective to reduce coronaviruses. That is why published data were reviewed to find out which temperature and exposure time is necessary for inactivation of coronaviruses.

A Medline search has been done on 20th March 2020. The following terms were used, always in combination with “coronavirus”: heat inactivation (17 hits), heat disinfection (5 hits), heat inactivate (5 hits), heat kill (1 hit), thermal inactivation (6 hits), thermal disinfection (2 hits), thermal inactivate (3 hits) and thermal kill (0 hits). Publications were included and results were extracted given they provided original data on human (Severe Acute Respiratory Syndrome [SARS] coronavirus and Middle East Respiratory Syndrome [MERS] coronavirus) or zoonotic coronaviruses (Transmissible Gastroenteritis Virus [TGEV], Mouse Hepatitis Virus [MHV] and Porcine Epidemic Diarrhoea Virus [PEDV]) and their inactivation by various temperatures used for thermal disinfection. Reviews were not included but screened for any information within the scope of this review.

A total of 10 studies with original data were found. Overall a thermal disinfection at 60°C for 30 min, 65°C for 15 min and 80°C for 1 min was effective to strongly reduce coronavirus infectivity by at least 4 log10 (Table 1 ).

Table I.

Heat inactivation of coronaviruses in test tube suspensions

Temperature Virus Strain/isolate Exposure time Reduction of viral infectivity (log10) Reference
4°C SARS-CoV Strain FFM-1 30 min 0.0 [4]
4°C PEDV Strain CV777 2 h 0.0 [5]
25°C MERS-CoV Strain Hu/France–FRA2_130569/2013 (FRA2) 2 h 0.0 [6]
31°C TGEV Strain D52 80 min 0.7 [7]
35°C TGEV Strain D52 80 min 1.2 [7]
39°C TGEV Strain D52 80 min 3.0 [7]
40°C MHV Strains MHV-2 and MHV-N 30 min 0.3 [8]
40°C PEDV Strain CV777 2 h
75 min#
1.0
4.7
[5]
43°C TGEV Strain D52 50 min 3.8 [7]
44°C PEDV Strain CV777 2 h
45 min#
1.5
4.7
[5]
44°C PEDV Strain CV777 10 min 0.3 [9]
47°C TGEV Strain D52 20 min 4.2 [7]
48°C PEDV Strain CV777 2 h
15 min#
4.7
4.7
[5]
48°C PEDV Strain CV777 10 min 1.0–1.7 [9]
51°C TGEV Strain D52 5 min 4.4 [7]
55°C TGEV Strain D52 2 min 4.6 [7]
56°C MERS-CoV Strain Hu/France–FRA2_130569/2013 (FRA2) 30 s
15 min
30 min
0.1–0.9
≥ 4.6
≥ 4.3
[6]
56°C SARS-CoV Strain Hanoi 5 min
10 min
30 min
5.8
6.4
> 6.4
[10]
56°C SARS-CoV Strain FFM-1 30 min 1.9–5.0 [4]
56°C SARS-CoV Strain Urbani 20 min ≥ 4.3 [11]
60°C MHV Strains MHV-2 and MHV-N 1 min
5 min
15 min
30 min
2.6–2.9
3.6–3.9
> 3.9
> 3.9
[8]
60°C SARS-CoV Strain FFM-1 30 min ≥ 5.0 [4]
60°C SARS-CoV Strain FFM-1 30 min
60 min
≥ 4.0
≥ 4.0
[12]
65°C SARS-CoV Strain Urbani 15 min ≥ 4.3∗∗ [11]
65°C MERS-CoV Strain Hu/France–FRA2_130569/2013 (FRA2) 30 s
15 min
30 min
0.9–3.6
≥ 4.9
≥ 4.9
[6]
65°C SARS-CoV Strain Urbani 10 min ≥ 4.3 [11]
65°C MHV Not described 15 min ≥ 6.0 [13]
80°C MHV Strains MHV-2 and MHV-N 1 min > 3.9 [8]

Not with anti-thrombin III as organic load;

∗∗

One outlier at 25 min with 3.6 log10 explained by the authors with an experimental error;

#

In porcine plasma.

The effect of heat is explained by thermal aggregation of the SARS-CoV membrane protein [2]. It was shown that the nucleocapsid protein of SARS-CoV is completely denatured in 10 min at 55°C [3]. Health care providers may now have an idea what parameter for thermal disinfection may be effective in case of a lack of supply of appropriate face masks. One limitation is that all data described here were obtained with coronaviruses in suspension. That is why it may be possible that the results on dry surfaces may be different but this appears to be unlikely. Our data do not allow to evaluate if the function of a face mask remains unchanged after heat treatment. If thermal disinfection is used for the re-use of masks all institutions should evaluate the effect on their own masks in use, as different brands of masks and different specifications (e.g. with or without cellulose) will react individually towards a combination of time and heat. Easy tests to do are “fitting” and “water-resistance”. In addition, the numbers of re-uses should be traced (mark at the side of mask per cycle) and its effects examined.

Conflict of interest statement

None declared.

References

  • 1.Mahase E. Novel coronavirus: Australian GPs raise concerns about shortage of face masks. BMJ (Clinical Research Ed) 2020;368:m477. doi: 10.1136/bmj.m477. [DOI] [PubMed] [Google Scholar]
  • 2.Lee Y.N., Chen L.K., Ma H.C., Yang H.H., Li H.P., Lo S.Y. Thermal aggregation of SARS-CoV membrane protein. Journal of Virological Methods. 2005;129:152–161. doi: 10.1016/j.jviromet.2005.05.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wang Y., Wu X., Wang Y., Li B., Zhou H., Yuan G. Low stability of nucleocapsid protein in SARS virus. Biochemistry. 2004;43:11103–11108. doi: 10.1021/bi049194b. [DOI] [PubMed] [Google Scholar]
  • 4.Rabenau H.F., Cinatl J., Morgenstern B., Bauer G., Preiser W., Doerr H.W. Stability and inactivation of SARS coronavirus. Med Microbiol Immunol. 2005;194:1–6. doi: 10.1007/s00430-004-0219-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Quist-Rybachuk G.V., Nauwynck H.J., Kalmar I.D. Sensitivity of porcine epidemic diarrhea virus (PEDV) to pH and heat treatment in the presence or absence of porcine plasma. Vet Microbiol. 2015;181:283–288. doi: 10.1016/j.vetmic.2015.10.010. [DOI] [PubMed] [Google Scholar]
  • 6.Leclercq I., Batejat C., Burguiere A.M., Manuguerra J.C. Heat inactivation of the Middle East respiratory syndrome coronavirus. Influenza and Other Respiratory Viruses. 2014;8:585–586. doi: 10.1111/irv.12261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Laude H. Thermal inactivation studies of a coronavirus, transmissible gastroenteritis virus. The Journal of General Virology. 1981;56:235–240. doi: 10.1099/0022-1317-56-2-235. [DOI] [PubMed] [Google Scholar]
  • 8.Saknimit M., Inatsuki I., Sugiyama Y., Yagami K. Virucidal efficacy of physico-chemical treatments against coronaviruses and parvoviruses of laboratory animals. Jikken Dobutsu Experimental Animals. 1988;37:341–345. doi: 10.1538/expanim1978.37.3_341. [DOI] [PubMed] [Google Scholar]
  • 9.Hulst M.M., Heres L., Hakze-van der Honing R.W., Pelser M., Fox M., van der Poel W.H.M. Study on inactivation of porcine epidemic diarrhoea virus, porcine sapelovirus 1 and adenovirus in the production and storage of laboratory spray-dried porcine plasma. J Appl Microbiol. 2019;126:1931–1943. doi: 10.1111/jam.14235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Kariwa H., Fujii N., Takashima I. Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions, and chemical reagents. The Japanese Journal of Veterinary Research. 2004;52:105–112. [PubMed] [Google Scholar]
  • 11.Darnell M.E., Taylor D.R. Evaluation of inactivation methods for severe acute respiratory syndrome coronavirus in noncellular blood products. Transfusion. 2006;46:1770–1777. doi: 10.1111/j.1537-2995.2006.00976.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Yunoki M., Urayama T., Yamamoto I., Abe S., Ikuta K. Heat sensitivity of a SARS-associated coronavirus introduced into plasma products. Vox Sanguinis. 2004;87:302–303. doi: 10.1111/j.1423-0410.2004.00577.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lelie P.N., Reesink H.W., Lucas C.J. Inactivation of 12 viruses by heating steps applied during manufacture of a hepatitis B vaccine. Journal of Medical Virology. 1987;23:297–301. doi: 10.1002/jmv.1890230313. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The Journal of Hospital Infection are provided here courtesy of Elsevier

RESOURCES